NovaBay Pharmaceuticals Inc (NYSE American:NBY)

3.31
Delayed Data
As of 11:49am ET
 -0.024 / -0.72%
Today’s Change
2.25
Today|||52-Week Range
5.00
-14.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues1.1M4.4M11.9M18.2M
 
 
 
 
 
Cost of Goods Sold254.0K1.1M2.4M2.7M
 
 
 
 
 
Depreciation And Amortization232.0K164.0K114.0K95.0K
 
 
 
 
 
 
Operating ExpensesGross Income568.0K3.1M9.4M15.4M
 
 
 
 
 
General Expenses17.4M24.1M20.6M22.8M
 
 
 
 
 
Research And Development9.5M6.0M1.6M410.0K
 
 
 
 
 
Total Operating Expenses17.9M25.4M23.0M25.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.9M-21.0M-11.1M-7.3M
 
 
 
 
 
Extraordinary Credit1.7M2.1M0.000.00
 
 
 
Extraordinary Charge--0.00-2.2M-101.0K
 
 
 
Other Expenses22.0K-96.0K164.0K12.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.2M-19.0M-13.1M-7.4M
 
 
 
 
 
Income Taxes-2.0K-12.0K-2.0K-3.0K
 
 
 
 
 
Net Income-15.2M-19.0M-13.2M-7.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.0M2.8M9.4M15.3M
 
 
 
 
 
Shares To Calculate EPS Diluted2.0M2.8M9.4M15.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.75-$6.82-$1.40-$0.48
 
 
 
 
 
EPS Diluted-$7.75-$6.82-$1.40-$0.48